Trial intelligence / Profile preview

Melatonin for Quality of Life in Elderly Metastatic Cancer

NCT02454855Phase 3Terminated

Sponsor
Centre Jean Perrin
Start
Jul 2015
Primary completion
May 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of melatonin in solid tumor, sponsored by Centre Jean Perrin. Started Jul 2015; status: terminated.

02

Drugs

melatonin
03

Conditions

solid tumor

Beyond the preview

Go deeper on NCT02454855.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02454855.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call